Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record.

The roles of magnetic resonance and endoscopic retrograde cholangiopancreatography (MRCP and ERCP) in the diagnosis of patients with suspected sclerosing cholangitis: a cost-effectiveness analysis

Meagher, S., Yusoff, I., Kennedy, W., Martel, M., Adam, V., Barkun, A. · 2007 · Endoscopy

Abstract

BACKGROUND AND STUDY AIMS: The optimal approach for diagnosing sclerosing cholangitis remains unclear in the face of competing imaging technologies. We aimed to determine the most cost-effective strategy. PATIENTS AND METHODS: A decision model compared three approaches in the work-up of patients with suspected sclerosing cholangitis; all included an initial test, with, if unsuccessful, performance of a second cholangiographic method. They were magnetic resonance cholangiopancreatography (MRCP) and endoscopic retrograde cholangiopancreatography (ERCP), termed "MRCP_ERCP", ERCP and MRCP ("ERCP_MRCP"), or ERCP and a repeat ERCP ("ERCP_ERCP"). The implications of true and false positive and negative results with regard to costs and procedural complications were considered, including that of a liver biopsy, if indicated as a result of a negative work-up in the face of persistent clinical suspicion. The unit of effectiveness adopted was that of a correct diagnosis. Probability assumptions were derived from published literature, while cost estimates were derived from time-motion microanalyses or a national database, and expressed in Canadian dollars at 2004 values. Sensitivity analyses, including clinically relevant threshold analyses, were carried out. RESULTS: The average cost-effectiveness ratios were $414 for MRCP_ERCP, $1101 for ERCP_MRCP and $1123 for ERCP_ERCP, per correct diagnosis. The ERCP_MRCP strategy was dominated (more expensive and less effective) by MRCP_ERCP, while ERCP_ERCP was more effective and more costly than MRCP_ERCP, at $289,292 per additional correct diagnosis. Sensitivity and threshold analyses confirmed the robustness of these findings. CONCLUSIONS: Based on the model assumptions, a strategy of initial MRCP, followed, if negative, by ERCP is currently the most cost-effective approach to the work-up of patients with suspected sclerosing cholangitis.

Overview

Integrity signals

Registry

Crossref · 10.1055/s-2007-966253

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 50

Metadata

Authors
Meagher, S., Yusoff, I., Kennedy, W., Martel, M., Adam, V., & Barkun, A.
Affiliations
  • Montreal General Hospital (CA)
  • UNSW Sydney (AU)
Venue
Endoscopy
Published
2007-03
Volume
39
Issue
3
Pages
222-228
ISSN
  • 0013-726X (ISSN-L)
  • 1438-8812
OpenAlex
W2048176301
Cited by
50
References
0
Citations by year
2024: 2 · 2023: 2 · 2022: 3 · 2021: 1 · 2020: 2 · 2019: 6 · 2018: 5 · 2017: 4 · 2016: 1 · 2015: 4 · 2014: 2 · 2013: 4 · 2012: 2
FWCI
2.48
Type
journal article
Language
en
Open access
closed
Locations
  • Endoscopy (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Gastroenterology › Gallbladder and Bile Duct Disorders
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Keywords
sclerosing cholangitis, magnetic resonance cholangiopancreatography, endoscopic retrograde cholangiopancreatography, diagnostic approach, cost-effectiveness, decision analysis, liver biopsy, diagnostic accuracy, cholangiography
MeSH terms
Adolescent, Adult, Aged, Cholangiopancreatography, Endoscopic Retrograde, Cost-Benefit Analysis, Diagnosis, Differential, Female, Follow-Up Studies, Humans, Male, Middle Aged, Probability, Retrospective Studies, Sensitivity and Specificity, Reproducibility of Results, Cholangitis, Sclerosing, Models, Statistical, Cholangiopancreatography, Magnetic Resonance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The roles of magnetic resonance and endoscopic retrograde cholangiopancreatography (MRCP and ERCP) in the diagnosis of patients with suspected sclerosing cholangitis: a cost-effectiveness analysis. https://app.cochat.ai/papers/10.1055/s-2007-966253
The paper
Meagher, S., Yusoff, I., Kennedy, W., Martel, M., Adam, V., & Barkun, A. (2007). The roles of magnetic resonance and endoscopic retrograde cholangiopancreatography (MRCP and ERCP) in the diagnosis of patients with suspected sclerosing cholangitis: a cost-effectiveness analysis. Endoscopy. https://doi.org/10.1055/s-2007-966253

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.